NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 14 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,128 | +2.1% | 500,000 | 0.0% | 0.01% | +18.2% |
| Q2 2023 | $462,430 | -1.6% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $470,000 | +2.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $458,750 | -3.0% | 500,000 | 0.0% | 0.01% | -8.3% |
| Q3 2022 | $473,000 | +1.5% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $466,000 | -13.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $541,000 | -2.7% | 500,000 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $556,000 | -17.6% | 500,000 | 0.0% | 0.01% | -7.1% |
| Q3 2021 | $675,000 | -22.1% | 500,000 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $866,000 | +12.3% | 500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $771,000 | -15.5% | 500,000 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $912,000 | +17.7% | 500,000 | 0.0% | 0.02% | -5.0% |
| Q3 2020 | $775,000 | +13.5% | 500,000 | 0.0% | 0.02% | +5.3% |
| Q2 2020 | $683,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 109,251,000 | $102,018,584 | 3.22% |
| Opti Capital Management, LP | 19,500,000 | $18,574 | 1.34% |
| Context Capital Management, LLC | 10,702 | $10,207 | 0.82% |
| PFM Health Sciences, LP | 17,500,000 | $16,341,500 | 0.77% |
| LINDEN ADVISORS LP | 21,366,000 | $19,993,448 | 0.20% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,595,000 | $1,543,041 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,667,000 | $6,225,645 | 0.03% |
| Rock Springs Capital Management LP | 500,000 | $472,128 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 0 | $933 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |